VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
PGThe Procter & Gamble Company
$150.38$351.4B
Research
OverviewAnalysisShould I Buy?
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

PG logoThe Procter & Gamble Company(PG)Earnings, Financials & Key Ratios

PG•NYSE
23.1× P/E·Price updated Jun 19, 2026
SectorConsumer DefensiveIndustryHousehold ProductsSub-IndustryHousehold Cleaning and Paper Goods
AboutThe Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands. The Grooming segment provides shave care products and appliances under the Braun, Gillette, and Venus brand names. The Health Care segment offers toothbrushes, toothpastes, and other oral care products under the Crest and Oral-B brand names; and gastrointestinal, rapid diagnostics, respiratory, vitamins/minerals/supplements, pain relief, and other personal health care products under the Metamucil, Neurobion, Pepto-Bismol, and Vicks brands. The Fabric & Home Care segment provides fabric enhancers, laundry additives, and laundry detergents under the Ariel, Downy, Gain, and Tide brands; and air care, dish care, P&G professional, and surface care products under the Cascade, Dawn, Fairy, Febreze, Mr. Clean, and Swiffer brands. The Baby, Feminine & Family Care segment offers baby wipes, taped diapers, and pants under the Luvs and Pampers brands; adult incontinence and feminine care products under the Always, Always Discreet, and Tampax brands; and paper towels, tissues, and toilet papers under the Bounty, Charmin, and Puffs brands. The company sells its products primarily through mass merchandisers, e-commerce, grocery stores, membership club stores, drug stores, department stores, distributors, wholesalers, specialty beauty stores, high-frequency stores, pharmacies, electronics stores, and professional channels, as well as directly to consumers. The Procter & Gamble Company was founded in 1837 and is headquartered in Cincinnati, Ohio.Show more
  • Revenue$84.28B+0.3%
  • EBITDA$23.3B+8.7%
  • Net Income$15.97B+7.4%
  • EPS (Diluted)6.51+8.1%
  • Gross Margin51.16%-0.5%
  • EBITDA Margin27.64%+8.3%
  • Operating Margin24.26%+10.0%
  • Net Margin18.95%+7.0%
  • ROE31.07%+1.9%

PG Key Insights

The Procter & Gamble Company (PG) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Dividend Aristocrat: 56 years of consecutive increases
  • ✓Excellent 3Y average ROE of 30.9%
  • ✓FCF machine: 16.7% free cash flow margin
  • ✓Healthy dividend yield of 2.7%
  • ✓Healthy 5Y average net margin of 18.3%

✗Weaknesses

No significant weaknesses identified

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Get notified when PG posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

PG Price & Volume

The Procter & Gamble Company (PG) stock price & volume — 10-year historical chart

Loading chart...

PG Growth Metrics

The Procter & Gamble Company (PG) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years1.77%
5 Years3.5%
3 Years1.67%
TTM3.33%

Profit CAGR

10 Years8.54%
5 Years4.16%
3 Years2.71%
TTM-17.94%

EPS CAGR

10 Years10.31%
5 Years5.59%
3 Years3.86%
TTM8.57%

Return on Capital

10 Years17.51%
5 Years21.47%
3 Years21.92%
Last Year22.99%

PG Recent Earnings

The Procter & Gamble Company (PG) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 11/12 qtrs (92%)●Beat Revenue 6/12 qtrs (50%)
Q2 2026Latest
Apr 24, 2026
Metric
Actual
Est
EPS
$1.59+1.9%
$1.56
Rev
$21.2B+3.4%
$20.5B
Q1 2026
Jan 22, 2026
Metric
Actual
Est
EPS
$1.88+1.1%
$1.86
Rev
$22.2B-0.4%
$22.3B
Q4 2025
Oct 24, 2025
Metric
Actual
Est
EPS
$1.99+4.7%
$1.90
Rev
$22.4B+0.9%
$22.2B
Q3 2025
Jul 29, 2025
Metric
Actual
Est
EPS
$1.48+4.2%
$1.42
Rev
$20.9B+0.2%
$20.8B
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestApr 24, 2026
$1.59vs $1.56+1.9%
$21.2Bvs $20.5B+3.4%
Q1 2026Jan 22, 2026
$1.88vs $1.86+1.1%
$22.2Bvs $22.3B-0.4%
Q4 2025Oct 24, 2025
$1.99vs $1.90+4.7%
$22.4Bvs $22.2B+0.9%
Q3 2025Jul 29, 2025
$1.48vs $1.42+4.2%
$20.9Bvs $20.8B+0.2%
Based on last 12 quarters of dataView full earnings history →

PG Peer Comparison

The Procter & Gamble Company (PG) competitors in Household Cleaning and Paper Goods — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
Institutional Holdings
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
UL logoULUnilever PLCDirect Competitor127.6B58.4022.161.94%10.16%61.19%1.36
KMB logoKMBKimberly-Clark CorporationDirect Competitor34.04B102.5616.90-14.17%12.81%131.68%4.34
CL logoCLColgate-Palmolive CompanyDirect Competitor71.79B89.4834.021.4%10.46%251.59%21.88
CHD logoCHDChurch & Dwight Co., Inc.Direct Competitor22.65B95.6431.671.57%11.81%17.45%0.55
ENR logoENREnergizer Holdings, Inc.Direct Competitor1.47B21.526.482.28%6.55%116.9%20.79
EL logoELThe Estée Lauder Companies Inc.Product Competitor30.62B84.81-26.92-8.46%-1.67%-6.29%2.44
REYN logoREYNReynolds Consumer Products Inc.Product Competitor5.03B23.8716.690.7%8.7%14.88%0.78
SPB logoSPBSpectrum Brands Holdings, Inc.Product Competitor1.95B83.9721.75-5.23%4.48%6.65%0.34

Compare PG vs Peers

The Procter & Gamble Company (PG) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs UL

Most directly comparable listed peer for PG.

Scale Benchmark

vs AMZN

Larger-name benchmark to compare PG against a more recognizable public peer.

Peer Set

Compare Top 5

vs UL, KMB, CL, CHD

PG Income Statement

The Procter & Gamble Company (PG) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
MetricJun'17Jun'18Jun'19Jun'20Jun'21Jun'22Jun'23Jun'24Jun'25TTM
Sales/Revenue
65.06B66.83B67.68B70.95B76.12B80.19B82.01B84.04B84.28B86.72B
Revenue Growth %
-0.37%2.73%1.27%4.83%7.28%5.35%2.27%2.48%0.29%3.33%
Cost of Goods Sold
32.64B34.43B34.77B35.25B37.11B42.16B42.76B40.85B41.16B43.07B
COGS % of Revenue
50.17%51.52%51.37%49.68%48.75%52.57%52.14%48.61%48.84%-
Gross Profit
32.42B▲ 0%
32.4B▼ 0.1%
32.92B▲ 1.6%
35.7B▲ 8.5%
39.01B▲ 9.3%
38.03B▼ 2.5%
39.25B▲ 3.2%
43.19B▲ 10.1%
43.12B▼ 0.2%
43.64B▲ 0%
Gross Margin %
49.83%48.48%48.63%50.32%51.25%47.43%47.86%51.39%51.16%50.33%
Gross Profit Growth %
0.09%-0.06%1.59%8.46%9.27%-2.51%3.2%10.05%-0.16%-
Operating Expenses
18.65B19.04B27.43B19.99B21.02B20.22B21.11B24.65B22.67B23.49B
OpEx % of Revenue
28.67%28.48%40.53%28.18%27.62%25.21%25.74%29.33%26.9%-
Selling, General & Admin
18.65B19.04B19.08B19.99B21.02B20.22B21.11B23.3B22.67B23.49B
SG&A % of Revenue
28.67%28.48%28.2%28.18%27.62%25.21%25.74%27.73%26.9%-
Research & Development
0000000000
R&D % of Revenue
----------
Other Operating Expenses
008.35B00001.34B0-1000K
Operating Income
13.77B▲ 0%
13.36B▼ 2.9%
5.49B▼ 58.9%
15.71B▲ 186.2%
17.99B▲ 14.5%
17.81B▼ 1.0%
18.13B▲ 1.8%
18.55B▲ 2.3%
20.45B▲ 10.3%
20.15B▲ 0%
Operating Margin %
21.16%19.99%8.11%22.14%23.63%22.21%22.11%22.07%24.26%23.24%
Operating Income Growth %
2.42%-2.93%-58.94%186.24%14.52%-0.96%1.8%2.27%10.28%-
EBITDA
16.59B16.2B8.31B18.72B20.72B20.62B20.85B21.44B23.3B21.87B
EBITDA Margin %
25.49%24.24%12.28%26.38%27.22%25.71%25.42%25.51%27.64%25.22%
EBITDA Growth %
0.41%-2.35%-48.69%125.23%10.7%-0.49%1.11%2.84%8.66%-4.35%
D&A (Non-Cash Add-back)
2.82B2.83B2.82B3.01B2.73B2.81B2.71B2.9B2.85B1.48B
EBIT
13.72B13.83B6.58B16.3B18.12B18.43B19.11B19.69B21.07B16.57B
Net Interest Income
-294M-259M-289M-310M-457M-388M-449M-452M-438M138M
Interest Income
171M247M220M155M45M51M307M473M469M427M
Interest Expense
465M506M509M465M502M439M756M925M907M-34M
Other Income/Expense
-509M-37M582M128M-371M182M219M216M-284M812M
Pretax Income
13.26B▲ 0%
13.33B▲ 0.5%
6.07B▼ 54.5%
15.83B▲ 160.9%
17.61B▲ 11.2%
18B▲ 2.2%
18.35B▲ 2.0%
18.76B▲ 2.2%
20.17B▲ 7.5%
20.96B▲ 0%
Pretax Margin %
20.38%19.94%8.97%22.32%23.14%22.44%22.38%22.32%23.93%24.18%
Income Tax
3.06B3.46B2.1B2.73B3.26B3.2B3.62B3.79B4.1B8.21B
Effective Tax Rate %
23.1%26%34.65%17.25%18.52%17.79%19.7%20.19%20.34%39.15%
Net Income
15.33B▲ 0%
9.75B▼ 36.4%
3.9B▼ 60.0%
13.03B▲ 234.3%
14.31B▲ 9.8%
14.74B▲ 3.0%
14.65B▼ 0.6%
14.88B▲ 1.5%
15.97B▲ 7.4%
12.72B▲ 0%
Net Margin %
23.56%14.59%5.76%18.36%18.79%18.38%17.87%17.7%18.95%14.66%
Net Income Growth %
45.85%-36.38%-60.03%234.28%9.82%3.05%-0.6%1.54%7.36%-17.94%
Net Income (Continuing)
10.19B9.86B3.97B13.1B14.35B14.79B14.74B14.97B16.07B12.76B
Discontinued Operations
5.22B000000000
Minority Interest
594M590M385M357M276M265M288M272M272M0
EPS (Diluted)
5.59▲ 0%
3.67▼ 34.3%
1.43▼ 61.0%
4.96▲ 246.9%
5.50▲ 10.9%
5.81▲ 5.6%
5.90▲ 1.5%
6.02▲ 2.0%
6.51▲ 8.1%
5.26▲ 0%
EPS Growth %
51.49%-34.35%-61.04%246.85%10.89%5.64%1.55%2.03%8.14%8.57%
EPS (Basic)
5.803.751.455.135.696.006.076.186.67-
Diluted Shares Outstanding
2.74B2.66B2.54B2.63B2.6B2.54B2.48B2.47B2.45B2.42B
Basic Shares Outstanding
2.6B2.53B2.5B2.54B2.51B2.46B2.37B2.36B2.45B2.42B
Dividend Payout Ratio
47.21%74.97%192.4%59.79%57.76%59.49%61.41%62.58%61.8%-

PG Balance Sheet

The Procter & Gamble Company (PG) balance sheet — assets, liabilities & shareholders' equity

MetricJun'17Jun'18Jun'19Jun'20Jun'21Jun'22Jun'23Jun'24Jun'25TTM
Total Current Assets
26.49B23.32B22.47B27.99B23.09B21.65B22.65B24.71B25.39B27.99B
Cash & Short-Term Investments
15.14B11.85B10.29B16.18B10.29B7.21B8.25B9.48B9.56B12.31B
Cash Only
5.57B2.57B4.24B16.18B10.29B7.21B8.25B9.48B9.56B12.31B
Short-Term Investments
9.57B9.28B6.05B0000000
Accounts Receivable
4.59B4.69B4.95B4.18B4.72B5.14B5.47B6.12B6.18B6.32B
Days Sales Outstanding
25.7725.5926.721.4922.6623.4124.3526.5726.7826.59
Inventory
4.62B4.74B5.02B5.5B5.98B6.92B7.07B7.02B7.55B7.85B
Days Inventory Outstanding
51.7150.2352.6756.9358.8559.9560.3862.6966.9565.82
Other Current Assets
2.14B2.05B2.22B2.13B02.37B1.86B2.09B2.1B1.51B
Total Non-Current Assets
93.91B94.99B92.62B92.71B96.22B95.56B98.18B97.66B99.84B100.39B
Property, Plant & Equipment
19.89B20.6B21.27B20.69B21.69B21.2B21.91B22.15B23.9B24.57B
Fixed Asset Turnover
3.27x3.24x3.18x3.43x3.51x3.78x3.74x3.79x3.53x3.57x
Goodwill
44.7B45.17B40.27B39.9B40.92B39.7B40.66B40.3B41.65B41.36B
Intangible Assets
24.19B23.9B24.21B23.79B23.64B23.68B23.78B22.05B21.91B21.53B
Long-Term Investments
0000192M140M0000
Other Non-Current Assets
5.13B5.31B6.86B8.33B9.77B10.84B11.83B13.16B12.38B12.93B
Total Assets
120.41B▲ 0%
118.31B▼ 1.7%
115.09B▼ 2.7%
120.7B▲ 4.9%
119.31B▼ 1.2%
117.21B▼ 1.8%
120.83B▲ 3.1%
122.37B▲ 1.3%
125.23B▲ 2.3%
128.38B▲ 0%
Asset Turnover
0.54x0.56x0.59x0.59x0.64x0.68x0.68x0.69x0.67x0.68x
Asset Growth %
-5.29%-1.74%-2.72%4.87%-1.15%-1.76%3.09%1.28%2.34%11.4%
Total Current Liabilities
30.21B28.24B30.01B32.98B33.13B33.08B35.76B33.63B36.06B38.23B
Accounts Payable
9.63B10.34B11.26B12.07B13.72B14.88B14.6B15.36B15.23B15.03B
Days Payables Outstanding
107.72109.65118.21124.99134.95128.85124.61137.29135.02129.31
Short-Term Debt
13.55B10.42B9.7B11.18B8.89B8.64B10.23B7.19B9.51B13.17B
Deferred Revenue (Current)
0000000000
Other Current Liabilities
3.6B3.97B4.41B5.26B5.53B4.88B5.75B5.33B5.74B25.06B
Current Ratio
0.88x0.83x0.75x0.85x0.70x0.65x0.63x0.73x0.70x0.73x
Quick Ratio
0.72x0.66x0.58x0.68x0.52x0.45x0.44x0.53x0.49x0.53x
Cash Conversion Cycle
-30.23-33.83-38.84-46.57-53.45-45.49-39.88-48.02-41.28-36.9
Total Non-Current Liabilities
34.42B37.19B37.51B40.85B39.52B37.27B38.01B38.19B36.89B35.41B
Long-Term Debt
18.04B20.86B20.39B23.54B23.1B22.85B24.38B25.27B25B23.85B
Capital Lease Obligations
38M85M0652M631M595M595M666M701M701M
Deferred Tax Liabilities
8.13B6.16B6.9B6.2B6.15B6.81B6.48B6.52B5.77B23.69B
Other Non-Current Liabilities
8.22B10.08B10.21B10.46B9.64B7.02B6.56B5.73B5.42B5.51B
Total Liabilities
64.63B65.43B67.52B73.82B72.65B70.35B73.76B71.81B72.95B73.65B
Total Debt
31.64B31.39B30.1B35.61B32.84B32.29B35.42B33.37B35.46B37.03B
Net Debt
26.07B28.82B25.86B19.43B22.55B25.08B27.18B23.89B25.91B24.72B
Debt / Equity
0.57x0.59x0.63x0.76x0.70x0.69x0.75x0.66x0.68x0.68x
Debt / EBITDA
1.91x1.94x3.62x1.90x1.58x1.57x1.70x1.56x1.52x1.69x
Net Debt / EBITDA
1.57x1.78x3.11x1.04x1.09x1.22x1.30x1.11x1.11x1.13x
Interest Coverage
29.51x27.34x12.92x35.05x36.09x41.99x25.28x21.28x23.23x-487.21x
Total Equity
55.78B▲ 0%
52.88B▼ 5.2%
47.58B▼ 10.0%
46.88B▼ 1.5%
46.65B▼ 0.5%
46.85B▲ 0.4%
47.06B▲ 0.5%
50.56B▲ 7.4%
52.28B▲ 3.4%
54.73B▲ 0%
Equity Growth %
-3.8%-5.19%-10.03%-1.47%-0.48%0.43%0.45%7.42%3.41%13.92%
Book Value per Share
20.3519.9118.7417.8517.9418.4518.9520.4521.3022.65
Total Shareholders' Equity
55.18B52.29B47.19B46.52B46.38B46.59B46.78B50.29B52.01B54.73B
Common Stock
4.01B4.01B4.01B4.01B4.01B4.01B4.01B4.01B4.01B0
Retained Earnings
96.12B98.64B94.92B100.24B106.37B112.43B118.17B123.81B129.97B135.42B
Treasury Stock
-93.72B-99.22B-100.41B-105.57B-114.97B-123.38B-129.74B-133.38B-138.7B0
Accumulated OCI
-14.63B-14.75B-14.94B-16.16B-13.74B-12.19B-12.22B-11.9B-12.14B-12.3B
Minority Interest
594M590M385M357M276M265M288M272M272M0

PG Cash Flow Statement

The Procter & Gamble Company (PG) cash flow — operating, investing & free cash flow history

MetricJun'17Jun'18Jun'19Jun'20Jun'21Jun'22Jun'23Jun'24Jun'25TTM
Cash from Operations
12.75B14.87B15.24B17.4B18.37B16.72B16.85B19.85B17.82B19.41B
Operating CF Margin %
19.6%22.25%22.52%24.53%24.13%20.86%20.54%23.62%21.14%-
Operating CF Growth %
-17.38%16.58%2.52%14.18%5.56%-8.97%0.75%17.79%-10.22%24.57%
Net Income
15.33B9.86B3.97B13.1B14.35B14.79B14.74B14.88B16.07B12.72B
Depreciation & Amortization
2.82B2.83B2.82B3.01B2.73B2.81B2.71B2.9B2.85B3.07B
Stock-Based Compensation
366M395M515M558M540M528M545M562M476M506M
Deferred Taxes
-601M-1.84B-411M-596M-258M-402M-453M-244M149M144M
Other Non-Cash Items
-4.71B601M7.98B115M631M144M524M2.19B755M-3.46B
Working Capital Changes
-443M3.02B368M1.21B371M-1.15B-1.22B-436M-2.47B2.46B
Change in Receivables
-322M-177M-276M634M-342M-694M-307M-766M45M-62M
Change in Inventory
71M-188M-239M-637M-309M-1.25B-119M-70M-324M-261M
Change in Payables
-149M1.39B1.86B1.92B1.39B1.43B313M1.81B-542M1.32B
Cash from Investing
-6.68B-3.51B-3.49B3.04B-2.83B-4.42B-3.5B-3.5B-3.82B-4.49B
Capital Expenditures
-3.38B-3.72B-3.35B-3.07B-2.79B-3.16B-3.06B-3.32B-3.77B-4.38B
CapEx % of Revenue
5.2%5.56%4.95%4.33%3.66%3.94%3.73%3.95%4.48%5.05%
Acquisitions
-491M-109M-3.94B-58M-34M-1.38B-765M-21M-11M-85M
Investments
----------
Other Investing
571M269M394M30M42M110M327M-161M-34M-24M
Cash from Financing
-8.57B-14.38B-9.99B-8.37B-21.53B-14.88B-12.15B-14.86B-14.04B-11.77B
Debt Issued (Net)
1.4B-1.24B-817M4.85B-3.9B1.89B2.94B-2.44B630M1.62B
Equity Issued (Net)
-5.2B-7B-5B-7.41B-11.01B-10B-7.35B-5.01B-4.79B-4.23B
Dividends Paid
-7.24B-7.31B-7.5B-7.79B-8.26B-8.77B-9B-9.31B-9.87B-10.18B
Share Repurchases
-5.2B-7B-5B-7.41B-11.01B-10B-7.35B-5.01B-6.5B-4.85B
Other Financing
2.47B1.18B3.32B1.98B1.64B2B1.27B1.91B-1M1.02B
Net Change in Cash
-1.53B▲ 0%
-3B▼ 95.7%
1.67B▲ 155.7%
11.94B▲ 615.1%
-5.89B▼ 149.3%
-3.07B▲ 47.8%
1.03B▲ 133.6%
1.24B▲ 19.8%
74M▼ 94.0%
3.19B▲ 0%
Free Cash Flow
9.37B▲ 0%
11.15B▲ 19.0%
11.89B▲ 6.7%
14.33B▲ 20.5%
15.58B▲ 8.8%
13.57B▼ 12.9%
13.79B▲ 1.6%
16.52B▲ 19.9%
14.04B▼ 15.0%
15.03B▲ 0%
FCF Margin %
14.4%16.68%17.57%20.2%20.47%16.92%16.81%19.66%16.66%17.33%
FCF Growth %
-22.7%19.01%6.68%20.47%8.75%-12.94%1.61%19.86%-15.01%0.02%
FCF per Share
3.424.204.685.465.995.345.556.685.726.22
FCF Conversion (FCF/Net Income)
0.83x1.52x3.91x1.34x1.28x1.13x1.15x1.33x1.12x1.18x
Interest Paid
518M529M497M434M531M451M721M878M896M0
Taxes Paid
3.71B2.83B3.06B3.55B3.82B3.82B4.28B4.36B4.55B0

PG Key Ratios

The Procter & Gamble Company (PG) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric201720182019202020212022202320242025TTM
Return on Equity (ROE)
26.94%17.95%7.76%27.58%30.59%31.53%31.2%30.48%31.07%23.78%
Return on Invested Capital (ROIC)
12.64%12.26%5.3%16.86%19.91%18.93%18.61%18.71%20.1%19.19%
Gross Margin
49.83%48.48%48.63%50.32%51.25%47.43%47.86%51.39%51.16%50.33%
Net Margin
23.56%14.59%5.76%18.36%18.79%18.38%17.87%17.7%18.95%14.66%
Debt / Equity
0.57x0.59x0.63x0.76x0.70x0.69x0.75x0.66x0.68x0.68x
Interest Coverage
29.51x27.34x12.92x35.05x36.09x41.99x25.28x21.28x23.23x-487.21x
FCF Conversion
0.83x1.52x3.91x1.34x1.28x1.13x1.15x1.33x1.12x1.18x
Revenue Growth
-0.37%2.73%1.27%4.83%7.28%5.35%2.27%2.48%0.29%3.33%
Related:PG Dividend History·PG Revenue History·PG Price History·PG P/E History·PG Financial Ratios·PG Institutional Holders

PG SEC Filings & Documents

The Procter & Gamble Company (PG) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Apr 24, 2026·SEC

Material company update

Apr 24, 2026·SEC

Material company update

Apr 14, 2026·SEC

10-K Annual Reports

1
FY 2025

Aug 4, 2025·SEC

10-Q Quarterly Reports

5
FY 2026

Apr 24, 2026·SEC

FY 2026

Jan 23, 2026·SEC

FY 2025

Oct 24, 2025·SEC

PG Frequently Asked Questions

The Procter & Gamble Company (PG) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

The Procter & Gamble Company (PG) reported $86.72B in revenue for fiscal year 2025. This represents a 146% increase from $35.28B in 1996.

The Procter & Gamble Company (PG) grew revenue by 0.3% over the past year. Growth has been modest.

Yes, The Procter & Gamble Company (PG) is profitable, generating $12.72B in net income for fiscal year 2025 (19.0% net margin).

Dividend & Returns

Yes, The Procter & Gamble Company (PG) pays a dividend with a yield of 2.67%. This makes it attractive for income-focused investors.

The Procter & Gamble Company (PG) has a return on equity (ROE) of 31.1%. This is excellent, indicating efficient use of shareholder capital.

The Procter & Gamble Company (PG) generated $15.03B in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

What if you invested $1,000 in PG back in 1996?

Total return calculator · dividends reinvested · 30+ years of data

See returns →

How much would $100/month in PG be worth today?

Dollar cost averaging calculator · DCA vs lump sum

Calculate →